Update on the management of neutropenia.
Dale
David C
DC
D019468:Disease Management; D006133:Growth Substances / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007239:Infections / Q000150:complications; D009369:Neoplasms / Q000150:complications / Q000628:therapy; D009503:Neutropenia / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics / Q000209:etiology
D006133:Growth Substances